CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions

Journal of Experimental Medicine

Volumn 183, Issue 5, 1996, Pages 2209-2218

  Oxenius, A ^a,e   Campbell, K A ^b   Maliszewski, C R ^b   Kishimoto, T ^c   Kikutani, H ^d   Hengartner, H ^a   Zinkernagel, R M ^a   Bachmann, M F ^a,f  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b AMGEN INC   (United States)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d OSAKA UNIVERSITY   (Japan)

^e INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

^f PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN;

ANIMAL CELL; ANTIBODY SPECIFICITY; ANTIGEN SPECIFICITY; ARTICLE; CELL INTERACTION; IMMUNE RESPONSE; LIGAND BINDING; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VESICULAR STOMATITIS VIRUS; VIRUS REPLICATION;

ANIMALS; ANTIBODY FORMATION; ANTIGENS, CD40; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CYTOKINES; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COOPERATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTRALIZATION TESTS; T-LYMPHOCYTES; TIME FACTORS; VACCINIA VIRUS;

EID: 0030014527     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.5.2209     Document Type: Article

References (59)

1. Noelle, R.J., M. Roy, D.M. Shepherd, I. Stamenkovic, J.A. Ledbetter, and A. Aruffo. 1992. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc. Natl. Acad. Sci. USA. 89: 6550-6554.
2. + T cells that induces contact-dependent B cell differentiation J. Exp. Med. 175:1091-1101.
3. Lederman, S., M.J. Yellin, G. Inghirami, J.J. Lee, D.M. Knowles, and L. Chess. 1992. Molecular interaction mediating T-B lymphocyte collaboration in human lymphoid follicles. J. Immunol. 149:3817-3826.
4. Parker, D.C. 1993. T cell-dependent B cell activation. Annu. Rev. Immunol. 11:331-360.
5. Foy, T.M., J.D. Laman, J.A. Ledbetter, A. Aruffo, E. Claassen, and R.J. Noelle. 1994. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med. 180:157-163.
6. Banchereau, J., F. Bazan, D. Blanchard, F. Brière, J.P. Galizzi, C. van Kooten, Y.J. Liu, F. Rousset, and S. Saeland. 1994. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:881-922.
7. Foy, T.M., D.M. Shepherd, F.H. Durie, A. Aruffo, J.A. Ledbetter, and R.J. Noelle. 1993. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J. Exp. Med. 178:1567-1575.
8. Van den Eertwegh, A.J.M., R.J. Noelle, M. Roy, D.M. Shepherd, A. Aruffo, J.A. Ledbetter, W. Boersma, and E. Claassen. 1993. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions. J. Exp. Med. 178:1555-1565.
9. Gray, D., P. Dullforce, and S. Jainandunsing. 1994. Memory B cell development but not germinal center formation is impaired by in vivo blockade of CD40-CD40 ligand interaction. J. Exp. Med. 180:141-155.
10. Lane, P., T. Brocker, S. Hubele, E. Padovan, A. Lanzavecchia, and F. McConnell. 1993. Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation. J. Exp. Med. 177:1209-1213.
11. Renshaw, B.R., W.C. Fanslow, R.J. Armitage, K.A. Campbell, D. Liggitt, B. Wright, B.L. Davison, and C.R. Maliszewski. 1994. Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180:1889-1900.
12. Kawabe, T., T. Naka, K. Yoshida, T. Tanaka, H. Fujiwara, S. Suematsu, N. Yoshida, T. Kishimoto, and H. Kikutani. 1994. The immune responses in CD40-deficient mice: Impaired immunoglobulin class switching and germinal center formation. Immunity. 1:167-178.
13. Xu, J., T.M Foy, J.D. Laman, E.A. Elliott, J.J. Dunn, T.J. Waldschmidt, J. Elsemore, R.J. Noelle, and R.A. Flavell. 1994. Mice deficient for the CD40 Ligand. Immunity. 1:423-431.
14. Aruffo, A., M. Farrington, D. Hollenbaugh, X. Li, A. Milatovich, S. Nonoyama, J. Bajorath, L.S. Grosmaire, R. Stenkamp, M. Neubauer et al. 1993. The CD40 ligand, gp 39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell. 72:291-300.
15. Allen, R.C., R.J. Armitage, M.E. Conley, H. Rosenblatt, N.A. Jenkins, N.G. Copeland, M.A. Bedell, S. Edelhoff, C.M. Disteche, and D.K. Simoneaux. 1993. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome (see comments). Science (Wash. DC). 259:990-993.
16. Korthauer, U., D. Graf, H.W. Mages, F. Brière, P. Munoreedevi, S. Malcolm, A.G. Ugazio, L.D. Notarangelo, R.J. Levinsky, and R.A. Kroczek. 1993. Defective expression of T cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature (Lond.). 361:539-541.
17. Disanto, J.P., J.Y. Bonnefoy, J.F. Gauchat, and A. Fischer. 1993. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature (Lond.). 361:541-543.
18. Farrington, M., L.S. Grosmaire, S. Nonoyama, S.H. Fischer, D. Hollenbaugh, J.A. Ledbetter, RJ. Noelle, A. Aruffo, and H.D. Ochs. 1994. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc. Natl. Acad. Sci. USA. 91:1099-1103.
19. Ling, N.R., I.C.M. MacLennan, and D. Mason. 1987. In Leucocyte Typing III: B-Cell and Plasma Cell Antigens: New and Previously Defined Clusters. A.J. McMichael, editor. Oxford University Press, Oxford. 302-335.
20. Freudenthal, P.S., and R.M. Steinmann. 1990. The distinct surface of human blood dendritic cells, as observed after an impoved isolation method. Proc. Natl. Acad. Sci. USA. 87: 7698-7702.
21. Schriever, F., A.S. Freedman, G. Freeman, E. Messner, G. Lee, J. Daley, and L.M. Nadler. 1989. Isolated follicular dendritic cells display a unique antigenic phenotype. J. Exp. Med. 169:2043-2048.
22. Clark, E.A., K.H. Grabstein, and G.L. Shu. 1992. Cultures human follicular dendritic cells. Growth characteristics and interaction with B lymphocytes. J. Immunol. 148:3327-3335.
23. Galy, A.H.M., and H. Spits. 1992. CD40 is functionally expressed on human thymic epithelial cells. J. Immunol. 149: 775-782.
24. Kitamura, D., J. Roes, R. Kühn, and K. Rajewski. 1992. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin in chain gene. Nature (Lond.). 350:423-426.
25. Mackett, M., T. Yilma, J.K. Rose, and B. Moss. 1985. Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle. Science (Wash. DC). 227:433-435.
26. Battegay, M., D. Moskophidis, H. Waldner, M.A. Bründler, Fung, W.P. Leung, T.W. Mak, H. Hengartner, and R.M. Zinkernagel. 1993. Impairment and delay of neutralizing antiviral antibody responses by virus specific cytotoxic T cells. J. Immunol. 151:5408-5415.
27. Matsuura, Y., R.D. Possee, H.A. Overton, and D. Bishop. 1987. Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins. J. Gen. Virol. 68:1233-1250.
28. Oxenius, A., M.F. Bachmann, P.G. Ashton-Rickardt, S. Tonegawa, R.M. Zinkernagel, and H. Hengartner. 1995. Presentation of endogenous viral proteins in association with major histocompatibility complex II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system. Eur. J. Immunol. 25:3402-3411.
29. Pruslin, F.H. 1991. Caveats and suggestions for the ELISA. J. Immunol. Methods. 137:27-35.
30. Chirmule, N. 1991. Misinterpretation of results of cytokine bioassays. J. Immunol. Methods. 137:141-144.
31. Mishell, B.B., and S.M. Shiigi. 1980. Selected Methods in Cellular Immunology. Freeman and Company, San Francisco. 347-350.
32. Charan, S., H. Hengartner, and R.M. Zinkernagel. 1986. Primary antibody responses to a well-defined and unique hapten are not enhanced by preimmunization with carrier: analysis in a viral model. Proc. Natl. Acad. Sci. USA. 83:2604-2608.
33. Roost, H.P., S. Charan, and R.M. Zinkernagel. 1990. Analysis of the kinetics of antiviral memory T help in vivo: characterization of short lived cross-reactive T help. Eur. J. Immunol. 20:2547-2554.
34. Scott, D.W., and R.K. Gershon. 1970. Determination of total and mercaptoethanol-resistant antibody in the serum sample. Clin. Exp. Immunol. 6:13-18.
35. Castelmur, I., C. DiPaolo, M.F. Bachmann, H. Hengartner, R.M. Zinkernagel, and T.M. Kündig. 1993. Comparison of the sensitivity of in vivo and in vitro assays for detection of antiviral cytotoxic T cell activity. Cell. Immunol. 151:460-466.
36. Cobbold, S.P., A. Jayasuriya, A. Nash, T.D. Prospero, and H. Waldmann. 1984. Therapy with monoclonal antibodies by elimination of T cell subsets in vivo. Nature (Lond.). 312:548-551.
37. Binder, D., and T.M. Kündig. 1991. Antiviral protection by CD8+ versus CD4+ T cells: CD8+ T cells correlating with cytotoxic activity in vitro are more efficient in antivaccinia virus protection than CD4-dependent interleukins. J. Immunol. 146:4301-4307.
38. Lawton, A.R., R. Asofsky, and M.B. Hylton. 1972. Suppression of immunological synthesis in mice. I. Effect of treatment with antibodies to u-chain. J. Exp. Med. 135:277-286.
39. Ron, Y., J. DeBaetselier, J. Gordon, J. Feldmann, and S. Segal. 1981. Defective induction of antigen-reactive proliferating T cells in B-cell deprived mice. Eur. J. Immunol. 11:964-968.
40. Janeway, C.A., Y. Ron, and K.E. Katz. 1987. The B cell is the initiating antigen-presenting cells in the peripheral lymph nodes. J. Immunol. 138:1051-1055.
41. Ron, Y., and J. Sprent. 1987. T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes. J. Immunol. 138:2848-2856.
42. Kurt-Jones, E.A., E.D. Liano, K.A. Hayglass, B. Benacerraf, M.S. Sym, and A.K. Abbas. 1988. The role of antigen-presenting B cells in vivo: studies of B deficient mice. J Immunol. 140:3773-3778.
43. van Ewijk, W., Y. Ron, J. Monaco, J. Kappler, P. Marrack, M. Le Meur, P. Gerlinger, B. Durand, C. Benoist, and D. Mathis. 1988. Compartmentalization of MHC class II gene expression in transgenic mice. Cell. 53:357-370.
44. Liu, Y., L. Ramarathinam, Y. Guo, D. Huszar, M. Trounstine, and M. Zhao. 1995. Gene-targeted B-deficient mice reveal a critical role for B cells in the CD4 T cell response. Intl. Immunol. 7:1353-1362.
45. Bachmann, M.F., R.U. Hoffmann, T.M. Kündig, K. Bürki, H. Hengartner, and R.M. Zinkernagel. 1993. The influence of antigen organisation on B cell responsiveness. Science (Wash. DC). 262:1448-1451.
46. Leist, T.P., S.P. Cobbold, H. Waldmann, M. Aguet, and R.M. Zinkernagel. 1987. Functional analysis of T lymphocyte subsets in antiviral host defense. J. Immunol. 138:2278-2281.
47. Bachmann, M.F., H. Hengartner, and R.M. Zinkernagel. 1995. T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction? Eur. J. Immunol. 25:3445-3451.
48. Moskophidis, D., and G.F. Lehmann. 1989. Virus-induced deiayed-type hypersensitivity reaction is sequentially mediated by CD8+ and CD4+ T lymphocytes. Proc. Natl. Acad. Sci. USA. 86:3291-3295.
49. Kündig, T., I. Castelmur, M.F. Bachmann, D. Abraham, D. Binder, H. Hengartner, and R.M. Zinkernagel. 1993. Fewer protective cytotoxic T cell epitopes than T helper cell epitopes on vesicular stomatitis virus. J. Virol. 67:3680-3683.
50. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1109-1118.
51. Grewal, I.S., J. Xu, and R.A. Flavell. 1995. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature (Lond.). 378:617-620.
52. van Essen, D., H. Kikutani, and D. Gray. 1995. CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature (Lond.). 378:620-623.
53. Han, S., K. Hathcock, B. Zheng, T.B. Kepler, R. Hodes, and G. Kelsoe. 1995. Cellular interaction in germinal centers. J. Immunol. 155:556-567.
54. Nishioka, Y., and P.E. Lipsky. 1994. The role of CD40-CD40 ligand interaction in human T cell-B collaboration. J. Immunol. 153:1027-1036.
55. Cerny, A., A.W. Hügin, S. Sutter, H. Bazin, H. Hengartner, and R.M. Zinkernagel. 1986. Immunity to lymphocytic choriomemngitis virus in B cell-depleted mice: evidence for B cell and antibody independent protection by memory T cells. Eur. J. Immunol. 16:913-917.
56. Stüber, E., W. Strober, and M. Neurath. 1996. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J. Exp. Med. 183:693-698.
57. Epstein, MM., F. Di Rosa, D. Jankovic, A. Sher, and P. Matzinger. 1995. Successful T cell priming in B cell-deficient mice. J. Exp. Med. 182:915-922.
58. Constant, S., N. Schweitzer, J. West, P. Ranney, and K. Bottomly. 1995. B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo. J. Immunol. 155:3734-3741.
59. Ruby, J., H. Bluethmann, M. Aguet, and I.A. Ramshaw. 1995. CD40 ligand has potent antiviral activity. Nat. Med. 1: 437-441.